C12N 2506/00
Differentiation of animal cells from one lineage to another
Official title: Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
C12N2506/00 (Differentiation of animal cells from one lineage to another) appears on 3,029 US grants and 6,853 published applications in this corpus.
Search patents in C12N- Granted patents
- 3,029
- Published applications
- 6,853
- Assignees
- 1,903
- Inventors
- 10,059
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 6 | 0 |
| 1998 | 7 | 0 |
| 1999 | 5 | 0 |
| 2000 | 8 | 0 |
| 2001 | 7 | 7 |
| 2002 | 9 | 48 |
| 2003 | 9 | 77 |
| 2004 | 9 | 83 |
| 2005 | 16 | 123 |
| 2006 | 20 | 111 |
| 2007 | 28 | 116 |
| 2008 | 26 | 103 |
| 2009 | 49 | 140 |
| 2010 | 51 | 165 |
| 2011 | 44 | 168 |
| 2012 | 83 | 202 |
| 2013 | 78 | 232 |
| 2014 | 124 | 226 |
| 2015 | 142 | 309 |
| 2016 | 174 | 352 |
| 2017 | 177 | 338 |
| 2018 | 221 | 344 |
| 2019 | 240 | 405 |
| 2020 | 208 | 447 |
| 2021 | 218 | 452 |
| 2022 | 185 | 532 |
| 2023 | 192 | 486 |
| 2024 | 236 | 512 |
| 2025 | 257 | 492 |
| 2026 | 197 | 383 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12N 2506/02From embryonic cellsIndexing code1,292
- C12N 2506/45From artificially induced pluripotent stem cellsIndexing code967
- C12N 2506/13From connective tissue cells, from mesenchymal cellsIndexing code737
- C12N 2506/11From blood or immune system cellsIndexing code332
- C12N 2506/03From non-embryonic pluripotent stem cellsIndexing code253
- C12N 2506/30From cancer cellsIndexing code107
- C12N 2506/08From cells of the nervous systemIndexing code102
- C12N 2506/09From epidermal cells, from skin cells, from oral mucosa cellsIndexing code100
All 17 subgroupsShow fewer
- C12N 2506/22From pancreatic cellsIndexing code43
- C12N 2506/14From hepatocytesIndexing code39
- C12N 2506/28From vascular endothelial cellsIndexing code35
- C12N 2506/04From germ cellsIndexing code30
- C12N 2506/25From renal cells, from cells of the urinary tractIndexing code20
- C12N 2506/23From cells of the gastro-intestinal tractIndexing code12
- C12N 2506/27From lung cells, from cells of the respiratory tractIndexing code11
- C12N 2506/24From cells of the genital tract, from non-germinal gonad cellsIndexing code5
- C12N 2506/07From endocrine cellsIndexing code4
Recent patents
- Induced pluripotent stem cell derived glial enriched progenitor cells for the treatment of white matter stroke6 Oct 2026US 12,751,976 B2The Regents of the University of California
- Composition for inducing direct cross differentiation of somatic cell into motor neuron, and method for using same6 Oct 2026US 12,753,385 B2Unist (Ulsan National Institute of Science and Technology)
- Production method for stage 5 neurons6 Oct 2026US 12,753,386 B2Ricoh Company, Ltd.
- Methods for manufacture of neuronal precursors6 Oct 2026US 12,753,387 B2Skin2Neuron Pty Ltd
- Composition for enhancing reprogramming efficiency from somatic cell to induced pluripotent stem cell, comprising mTOR activator, and method for enhancing reprogramming efficiency by using same6 Oct 2026US 12,753,394 B2Korea University Research and Business Foundation
- Intra-striatal co-transplantation of autologous treg and mda cells in parkinson's disease cell therapy8 Oct 2026US 2026/0306543 A1The McLean Hospital Corporation
- Retinal pigment epithelium cell therapy8 Oct 2026US 2026/0306548 A1The Regents of the University of California
- Application of stem cells or transgenic stem cells8 Oct 2026US 2026/0306716 A1Anhui Longhui Stem Cell Biotechnology Co., Ltd
- Nk cell compositions and preparations for immunotherapy and methods for their production8 Oct 2026US 2026/0308226 A1Deverra Therpaeutics Inc.
- Cd4+ cytotoxic t cells and methods of use thereof8 Oct 2026US 2026/0308522 A1Dana-Farber Cancer Institute, Inc.
Most cited
By later US patents
- Primate embryonic stem cells641US 5,843,780 AWisconsin Alumni Research Foundation · 1998
- Primate embryonic stem cells497US 6,200,806 B1Wisconsin Alumni Research Foundation · 2001
- Adipose-derived stem cells and lattices313US 6,777,231 B1The Regents of the University of California · 2004
- Use of adipose tissue-derived stromal cells for chondrocyte differentiation and cartilage repair304US 6,429,013 B1Artecel Science, Inc. · 2002
- Isolation propagation and directed differentiation of stem cells from embryonic and adult central nervous system of mammals223US 5,753,506 ACNS Stem Cell Technology, Inc. · 1998